Jérémy Blanc presented survival data results from AURA trial: Avelumab as neoadjuvant therapy in patients with urothelial non-metastatic muscle invasive bladder cancer: a multicenter, randomized, non-comparative, phase II study (Oncodistinct 004) at ASCO 2024 in Chicago, USA
We are pleased to announce that the next Oncodistinct Meeting will take place on Thursday 17th & Friday 18th October 2024 at the Institut Paoli-Calmettes in Marseille, France. Please save the date !
First results from our BRAINSTORM 🧠Program was presented by our our executive Officer Nuria Kotecki at AACR24 and EBCC14.
Meeting of the Oncodistinct network on January 25 and 26, 2024 at the Institut Jules Bordet in Brussels.
Follow us on our Oncodistinct twitter account: @oncodistinct. We will keep you informed about Oncodistinct studies as well as other studies in the field of
